Overview

Testing Obeticholic Acid (OCA) for Familial Adenomatous Polyposis (FAP)

Status:
Not yet recruiting
Trial end date:
2024-02-28
Target enrollment:
Participant gender:
Summary
This is a trial that intends to evaluate the effect of treatment with the drug obeticholic acid in the treatment of the Familial Adenomatous Polyposis condition.
Phase:
Phase 1
Details
Lead Sponsor:
M.D. Anderson Cancer Center